Best Practice & Research Clinical Haematology
Volume 20, Issue 1 , Pages 57-65, March 2007

Treatment of relapsed or refractory acute promyelocytic leukemia

  • Martin S. Tallman (Professor of Medicine)

      Affiliations

    • Corresponding Author InformationTel.: +1 312 695 6180; Fax: +1 312 695 6189.

Northwestern University Feinberg School of Medicine, Division of Hematology-Oncology, Robert H. Lurie Comprehensive Cancer Center, 676 N St. Clair Street, Suite 850, Chicago, IL 60611, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(06)00083-1

doi:10.1016/j.beha.2006.11.002

Best Practice & Research Clinical Haematology
Volume 20, Issue 1 , Pages 57-65, March 2007

Article Tools

* Image Usage & Resolution